
Edap Tms SA
NASDAQ:EDAP

Gross Margin
Edap Tms SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
FR |
![]() |
Edap Tms SA
NASDAQ:EDAP
|
51m USD |
40%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
221.6B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
138.9B USD |
68%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
134.8B USD |
64%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.1B USD |
66%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.7B USD |
45%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
49.6B EUR |
38%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
41.2B USD |
79%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.3B CNY |
64%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33B USD |
61%
|
Edap Tms SA
Glance View
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Edap Tms SA's most recent financial statements, the company has Gross Margin of 40.4%.